Patient access + solutions
We take a patient- and system-informed approach to designing access solutions that are practical, sustainable, and aligned with policy, clinical, and regulatory requirements. Our approach typically involves:
- Access landscape assessment and barrier identification to understand the system, policy, and practical challenges facing patients and providers.
- Program co-design with clinicians, patients, and internal teams to ensure access solutions are fit-for-purpose, compliant, and scalable.
- Integration of evidence generation and access planning to align real-world data, patient support, and reimbursement needs.
- Regulatory and safety alignment to ensure pharmacovigilance, reporting, and compliance are embedded from the outset.
- Ongoing evaluation and optimisation of access programs to assess reach, impact, and value — and adapt as needed.
We deliver a range of tailored solutions to help our clients overcome access barriers and improve outcomes for patients, payers, and providers. These include:
- Quality Use of Medicines (QUM) plans to support safe, effective, and equitable use of therapies — aligned with Australian policy, PBAC and system priorities.
- Patient access program development and operations to improve enrolment, support adherence, and reduce barriers to treatment.
- Pharmacovigilance program design and evaluation to meet safety monitoring requirements in patient support settings.
- Real-world evidence generation to support access, guideline inclusion, or value demonstration.
- Medical writing and evidence translation to communicate value and impact to diverse stakeholders.
- Target population expansion strategies to broaden access through revised eligibility, indication expansion, or service innovation.
Reports:
Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections
Evohealth Report Fighting Superbugs: Ensuring Australia is ready to…
Cell and gene therapies: Rising to the challenge Scorecard 2023
Scorecard 2023 Measuring Australia’s progress towards timely and…
Time to Act: protecting our children from RSV
Evohealth Report Time to Act: protecting our children from RSVRespiratory..
Preparing Australia: Designing an Australian Centre for Disease Control (CDC)
For many Australians, the COVID-19 pandemic has been their defining…
Cell and gene therapies: Rising to the challenge Scorecard 2023
Evohealth White Paper The burden of cancer in AustraliaIn Australia,…
ASCVD in Taiwan: A public health priority
Evohealth White Paper ASCVD in Taiwan: A public health…
Cell and gene therapies: Rising to the challenge
Evohealth White Paper Cell and gene therapies: Rising to the…
Australia’s Cholesterol Heartache
A simple roadmap for urgent action on cholesterol managementAustralia has…